[1] 叶波,杨龙海,刘向阳.最新国际肺癌TNM分期标准(第7版)修订稿解读.中国医刊,2008,43(1):21-23.
[2] Cyr JE, Pearson DA, Nelson CA, et al. Isolation, characterization, and biological evaluation of syn and anti diastereomers of[(99m) Tc]technetium depreotide:a somatostatin receptor binding tumor imaging agent. J Med Chem, 2007, 50(18):4295-4303.
[3] Shih WJ, Samayoa L. Tc-99m depreotide detecting malignant pulmonary nodules:histopathologic correlation with semiquantitative tumor-to-normal lung ratio. Clin Nucl Med, 2004, 29(3):171-176.
[4] Alzahouri K, Vehen M, Arveux P, et al. Management of SPN in France. Pathways for definitive diagnosis of solitary pulmonary nodule:a multicentre study in 18 French districts. BMC Cancer, 2008, 8:93.
[5] Winer-Muram HT. The solitary pulmonary nodule. Radiology, 2006, 239(1):34-49.
[6] Ost D, Fein AM, Feinsilver SH. Clinical practice. The solitary pulmonary nodule. N Engl J Med, 2003, 348(25):2535-2542.
[7] Ambrosini V, Rubello D. Is there an ideal diagnostic algorithm in solitary pulmonary nodules?. Respiration, 2006, 73(5):587-589.
[8] Diederich S, Das M. Solitary pulmonary nodule:detection and management. Cancer Imaging, 2006, 6(Spec No A):S42-S46.
[9] Henschke CI, Yankelevitz DF, Naidich DP, et al. CT screening for lung cancer:suspiciousness of nodules according to size on baseline scans. Radiology, 2004, 231(1):164-168.
[10] Orlacchio A, Schillaci O, Antonelli L, et al. Solitary pulmonary nodules:morphological and metabolic characterisation by FDGPET-MDCT. Radiol Med, 2007, 112(2):157-173.
[11] Kim SK, Allen-Auerbach M, Gotdin J, et al. Accuracy of PET/CT in characterization of solitary pulmonary lesions. J Nucl Med, 2007, 48(2):214-220.
[12] Cronin P, Dwamena BA, Kelly AM, et al. Solitary pulmonary nodules:meta-analytic comparison of cross-sectional imaging modalities for diagnosis of malignancy. Radiology, 2008, 246(3):772-782.
[13] Halley A, Hugentobler A, Icard P, et al. Efficiency of 18F-FDG and 99mTc-depreotide SPECT in the diagnosis of malignancy of solitary pulmonary nodules. Eur J Nucl Med Mol Imaging, 2005, 32(9):1026-1032.
[14] Naalsund A, Maublant J. The solitary pulmonary nodule-is it malignant or benign? Diagnostic performance of 99mTc-depreotide SPECT. Respiration, 2006, 73(5):634-641.
[15] Plachcinska A, Mikolajczak R, Maecke H, et al. Efficacy of 99mTc-EDDA/HYNIC-TOC scintigraphy in differential diagnosis of solitary pulmonary nodules. Cancer Biother Radiopharm, 2004, 19(5):613-620.
[16] Plachcinka A, Mikolajczak R, Kozak J, et al. Comparative analysis of 99mTc-depreotide and 99mTc-EDDA/HYNIC-TOC thorax scintigrams acquired for the purpose of differential diagnosis of solitary pulmonary nodules. Nucl Med Rev Cent East Eur, 2006, 9(1):24-29.
[17] Axelsson R, Herlin G, Baath M, et al. Role of scintigraphy with technetium-99m depreotide in the diagnosis and management of patients with suspected lung cancer. Acta Radiol, 2008, 49(3):295-302.
[18] Boundas D, Karatzas N, Moralidis E, et al. Comparative evaluation of 99mTc-depreotide and 201T1 chloride single photon emission tomography in the characterization of pulmonary lesions. Nucl Med Commun, 2007, 28(7):533-540.
[19] Ferran N, Rieart Y, Lopez M, et al. Characterization of radiologieally indeterminate lung lesions:99mTc-depreotide SPECT versus 18F-FDG PET. Nucl Med Commun, 2006, 27(6):507-514.
[20] Chcialowski A, Dziuk E, From S, et al. Technetium99 labelled synthetic somatostatin analogue (depreotide) in the diagnosis of peripheral solitary pulmonary nodules. Pal Arch Med Wewn, 2004, 112(3):1031-1038.
[21] Bååth M, Kölbeek KG, Danielsson R. Somatostatin receptor scintigraphy with 99mTc-Depreotide (NeoSpect) in discriminating between malignant and benign lesions in the diagnosis of lung cancer:a pilot study. Acta Radiol, 2004, 45(8):833-839.
[22] Martins T, Lino JS, Ramos S, et al. 99mTc-depreotide scintigraphy in the evaluation of indeterminate pulmonary lesions:clinical experience. Cancer Biother Radiopharm, 2004, 19(2):253-259.
[23] Kahn D, Menda Y, Kernstine K, et al. The utility of 99mTcdepreotide compared with F-18 fluorodeoxyglucose positron emission tomography and surgical staging in patients with suspected non-small cell lung cancer. Chest, 2004, 125(2):494-501.
[24] Danielsson R, Baath M, Svensson L, et al. Imaging of regional lymph node metastases with 99mTc-depreotide in patients with lung cancer. Eur J Nucl Med Mol Imaging, 2005, 32(8):925-931.
[25] Mena E, Camacho V, Estorch M, et al. 99mTc-depreotide seintigraphy of bone lesions in patients with lung eaneer. Eur J Nuel Med Mol Imaging, 2004, 31(10):1399-1404.